[HTML][HTML] Translation imaging in Parkinson's disease: focus on neuroinflammation
S Belloli, M Morari, V Murtaj, S Valtorta… - Frontiers in aging …, 2020 - frontiersin.org
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the
substantia nigra pars compacta (SNpc) and the appearance of α-synuclein insoluble …
substantia nigra pars compacta (SNpc) and the appearance of α-synuclein insoluble …
[HTML][HTML] Ozone pollution, oxidative stress, synaptic plasticity, and neurodegeneration
PC Bello-Medina, E Rodríguez-Martínez… - Neurología (English …, 2022 - Elsevier
Introduction Overpopulation and industrial growth result in an increase in air pollution,
mainly due to suspended particulate matter and the formation of ozone. Repeated exposure …
mainly due to suspended particulate matter and the formation of ozone. Repeated exposure …
[HTML][HTML] Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery
After advanced age, female sex is the major risk factor for Alzheimer's disease (AD). The
biological mechanisms underlying the increased AD risk in women remain largely …
biological mechanisms underlying the increased AD risk in women remain largely …
Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug‐naive Parkinson's disease
H Wilson, G Pagano, ER de Natale… - Movement …, 2020 - Wiley Online Library
Background Dysfunction of mitochondrial energy generation may contribute to
neurodegeneration, leading to synaptic loss in Parkinson's disease (PD). The objective of …
neurodegeneration, leading to synaptic loss in Parkinson's disease (PD). The objective of …
[HTML][HTML] Novel PET biomarkers to disentangle molecular pathways across age-related neurodegenerative diseases
There is a need to disentangle the etiological puzzle of age-related neurodegenerative
diseases, whose clinical phenotypes arise from known, and as yet unknown, pathways that …
diseases, whose clinical phenotypes arise from known, and as yet unknown, pathways that …
[HTML][HTML] PET imaging in animal models of Parkinson's disease
R Ni - Behavioural Brain Research, 2023 - Elsevier
Alpha-synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies and
multiple system atrophy, are characterized by aberrant accumulation of alpha-synuclein and …
multiple system atrophy, are characterized by aberrant accumulation of alpha-synuclein and …
[HTML][HTML] Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
CC Real, KH Binda, MB Thomsen… - Current …, 2023 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a debilitating neurodegenerative multisystem disorder leading
to motor and non-motor symptoms in millions of individuals. Despite intense research, there …
to motor and non-motor symptoms in millions of individuals. Despite intense research, there …
[HTML][HTML] Automated Synthesis of 18F-BCPP-EF {2-tert-Butyl-4-Chloro-5-{6-[2-(2[18F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2H-Pyridazin-3-One for Imaging of …
Mitochondrial complex I (MC-I) is an essential component of brain bioenergetics and can be
quantified and studied using positron emission tomography (PET). A specific high affinity …
quantified and studied using positron emission tomography (PET). A specific high affinity …
Cortical serotonergic and catecholaminergic denervation in MPTP-treated parkinsonian monkeys
GJ Masilamoni, A Weinkle, SM Papa, Y Smith - Cerebral cortex, 2022 - academic.oup.com
Decreased cortical serotonergic and catecholaminergic innervation of the frontal cortex has
been reported at early stages of Parkinson's disease (PD). However, the limited availability …
been reported at early stages of Parkinson's disease (PD). However, the limited availability …
Animal model of Parkinson disease: Neuroinflammation and apoptosis in the 6-hydroxydopamine-induced model
D Hernandez-Baltazar, R Nadella… - … Animal Models of …, 2018 - books.google.com
Hydroxydopamine (6-OHDA), a synthetic neurotoxin, has been used to generate animal
models of Parkinson's disease (PD). Even though 6-OHDA induced neurodegenerative …
models of Parkinson's disease (PD). Even though 6-OHDA induced neurodegenerative …